Reclassification of variants of uncertain significance in neonatal genetic diseases: implications from a clinician’s perspective
- 12 May 2025
- journal article
- research article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 70 (8) , 405-413
Abstract
Although whole-exome sequencing (WES) is now widely used to diagnose neonatal genetic diseases, the genetic causes in over half of the cases remain unresolved, primarily due to variants of uncertain significance (VUS). Therefore, reclassifying VUS may be an effective strategy to improve WES’s diagnostic yield. However, not all reclassification approaches are suitable for clinicians. Patients in the neonatal unit of Hebei Provincial Children’s Hospital who underwent WES for suspected genetic diseases and demonstrated VUS were re-evaluated from January 2019 to December 2023 using user-friendly methods. A total of 676 individuals were tested, with 101 phenotype-associated VUS identified in 82 patients. Thirty (29.7%) VUS classifications were changed: 24 were upgraded to likely pathogenic or pathogenic, and 6 were downgraded to likely benign. VUS reclassification clarified the molecular diagnosis in 19 cases, increasing the WES diagnostic rate from 30.2% to 33.0%. Computational prediction contributed the most to reclassification, whereas clinical phenotype-related evidence was also particularly significant in upgrading variants. Moreover, phenotype-associated VUS with a score of ≥3 points are more likely to be classified as likely pathogenic or pathogenic, thus requiring more attention. This study provides a practical reference for clinicians in managing VUS reclassification.Keywords
Funding Information
- Government Funded Clinical Medicine Excellent Talent Training Project
This publication has 28 references indexed in Scilit:
- Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic TestingJAMA Network Open, 2023
- Fitting a naturally scaled point system to the ACMG/AMP variant classification guidelinesHuman Mutation, 2020
- Changes in genetic variant results over time in pediatric cardiomyopathy and electrophysiologyJournal of Genetic Counseling, 2020
- Clinical Interpretation of Sequence VariantsCurrent Protocols in Human Genetics, 2020
- Reclassification of Variants of Uncertain Significance in Children with Inherited Arrhythmia Syndromes is Predicted by Clinical FactorsPediatric Cardiology, 2019
- Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelinesBreast Cancer, 2019
- Clinical Utility of Reinterpreting Previously Reported Genomic Epilepsy Test Results for Pediatric PatientsJAMA Pediatrics, 2019
- Physician interpretation of variants of uncertain significanceFamilial Cancer, 2018
- Use of Exome Sequencing for Infants in Intensive Care UnitsJAMA Pediatrics, 2017
- Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic ConditionsJAMA Pediatrics, 2017